The role of infectious agents in pulmonary and systemic vascular disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.7, 2001-07, pp. : 1093-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Vascular Disease in Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 401-407

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic inflammation and mortality in chronic obstructive pulmonary disease

By Sin Don D. Man S.F. P.

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 141-147

NRC Research Press

Access to resources Recommend Favorite

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1953-1962

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Role of Vascular Progenitor Cells in Cardiovascular Disease

Current Pharmaceutical Design, Vol. 15, Iss. 24, 2009-08 ,pp. : 2760-2768

Bentham Science Publishers

Access to resources Recommend Favorite